PEX11B
protein-codingperoxisomal biogenesis factor 11 beta, the group of Peroxins
Gene summary
The protein encoded by this gene facilitates peroxisomal proliferation and interacts with PEX19. The encoded protein is found in the peroxisomal membrane. Several transcript variants, some protein-coding and some not protein-coding, have been found for this gene. [provided by RefSeq, Dec 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013967
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013967
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0019609
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013967
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013967
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0019234
Submitter: ClinGen
The relationship between PEX11B and peroxisome biogenesis disorder (type 14B included), an autosomal recessive disorder, was evaluated using the ClinGen Clinical Validity Framework as of January, 2020. PEX11B encodes an integral peroxisome membrane protein involved in peroxisome elongation and division. Peroxisomal biogenesis disorders are caused by defects in various stages of peroxisomal protein import and/or peroxisome biogenesis, involving at least 14 PEX genes. The PEX11 protein family comprises three isoforms, PEX11α, PEX11β and PEX11γ, encoded by PEX11A, PEX11B and PEX11G genes, respectively (Waterham and Ebberink 2012, PMID 22871920). While PEX11A and PEX11G have not been reported in relation to PBDs in humans, a few patients with mild PBD phenotype have been described with PEX11B mutations. A common feature observed in all affected individuals has been bilateral congenital cataracts. PEX11B was first reported in relation to autosomal recessive Peroxisome biogenesis disorder in 2012. (Ebberink et al, 2012; PMID: 22581968). At least 5 nonsense or deletion variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Summary of Case Level Data (7 points): Variants in this gene have been reported in at least 5 probands in 3 publications (PMID: 22581968, 28129423, 31724321). The mechanism for disease is expected to be homozygous loss of function. Summary of experimental data (4.5 points): This gene-disease association is supported by in vitro functional assays (PMIDs 22581968, 21669930, 24234511) and a mouse model (PMID: 12024045). PEX11B interacts with PEX19 (PMID: 12096124). In summary, PEX11B is definitively associated with autosomal recessive peroxisome biogenesis disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Peroxisomal Disorders GCEP on January 17, 2020 (SOP Version 7).
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Renal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PEX11B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003846.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 66 | 69 | |||
| missense | 128 | 4 | 132 | |||
| nonsense | 2 | 5 | 1 | 8 | ||
| start loss | 2 | 2 | ||||
| frameshift | 2 | 6 | 8 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 4 | 15 | 132 | 70 | 0 | 221 |
Highest pathogenic variant AF is 0.000009916012
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003837.1 | 4 | MANE Select | |
| Ensembl | ENSP00000358312.3 | 4 | MANE Select | |
| RefSeq | NP_001171724.1 | 4 | Standard | |
| Ensembl | ENSP00000414018.1 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Peroxisome - Homo sapiens (human)
Biological Process
- peroxisome organization
- signal transduction
- peroxisome fission
- regulation of peroxisome size
- protein homooligomerization
Molecular Function
- protein binding
- protein homodimerization activity
Cellular Component
- mitochondrion
- peroxisome
- peroxisomal membrane
- integral component of peroxisomal membrane
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000369306
- Coding exons
- 4
- Length
- 7479
- Individuals with no LoFs
- 125722
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 25
- Defined
- 125747
- p
- 0.0000994
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.305 | 156 | 146 | 1.07 | 0.00000837 | 1603 |
| Missense (PolyPhen) | 60 | 53.775 | 1.1158 | 638 | ||
| Synonymous | 0.898 | 49 | 57.7 | 0.850 | 0.00000290 | 596 |
| Loss of Function | 1.36 | 8 | 13.4 | 0.599 | 9.37e-7 | 126 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000090 | 0.000088 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in peroxisomal proliferation (PubMed:9792670). May regulate peroxisome division by recruiting the dynamin-related GTPase DNM1L to the peroxisomal membrane (PubMed:12618434). Promotes membrane protrusion and elongation on the peroxisomal surface (PubMed:20826455). {ECO:0000269|PubMed:12618434, ECO:0000269|PubMed:20826455, ECO:0000269|PubMed:9792670}.;
- Disease
- DISEASE: Peroxisome biogenesis disorder 14B (PBD14B) [MIM:614920]: An autosomal recessive peroxisome biogenesis disorder characterized clinically by mild intellectual disability, congenital cataracts, progressive hearing loss, and polyneuropathy. Additionally, recurrent migraine-like episodes following mental stress or physical exertion, not a common feature in peroxisome disorders, are observed. {ECO:0000269|PubMed:22581968}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.191
Intolerance Scores
- LoFtool
- 0.877
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 33.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.980
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |